Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Magdalena Gherardi

Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent Under Conditions of Preexisting Immunity to the Vector

Journal of Virology

English

Related publications

Highly Attenuated Modified Vaccinia Virus Ankara (MVA) as an Effective Recombinant Vector: A Murine Tumor Model

Molecular Medicine

Infectious Diseases

Occupational Health

English

088 Skin Delivery of Modified Vaccinia Ankara (MVA) Virus Generates Superior Protective Pulmonary Immunity

Journal of Investigative Dermatology

Molecular Biology

English

834 Rational Design of Recombinant Modified Vaccinia Virus Ankara for Cancer Immunotherapy

Journal of Investigative Dermatology

Molecular Biology

English

Attenuation and Immunogenicity of Host-Range Extended Modified Vaccinia Virus Ankara Recombinants

Molecular Medicine

Infectious Diseases

Occupational Health

English

SPI-1 Is a Missing Host-Range Factor Required for Replication of the Attenuated Modified Vaccinia Ankara (MVA) Vaccine Vector in Human Cells

Molecular Biology

English

Enveloped Virus Is the Major Virus Form Produced During Productive Infection With the Modified Vaccinia Virus Ankara Strain

English

Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice Against Lethal Challenge

PLoS Neglected Tropical Diseases

Infectious Diseases

Occupational Health

English

Can Readmission Rates Be Used as an Outcome Indicator?

English

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

Journal of Virology

English